Ocular gene therapy

Details Ocular gene therapy Ocular gene therapy

A - Human Necessities

61

K

A61K 48/00 (2006.01) A61K 31/7088 (2006.01) A61K 38/39 (2006.01) A61P 27/02 (2006.01)

Patent

CA 2496820

Methods are provided for the treatment of VEGF-induced retinal detachment or retinal edema by increasing, in an individual afflicted with VEGF-induced retinal detachment or retinal edema, in vivo concentrations of an endostatin protein in the ocular tissues of the individual to a retinal detachment or retinal edema inhibiting effective amount.

La présente invention concerne des techniques de traitement de la néovascularisation choroïdienne d'une personne atteinte de cette affection, par une augmentation des concentrations in vivod'une protéine endostatine dans les tissus oculaires de cette personne dans une quantité efficace pour inhiber la néovascularisation choroïdienne, la protéine endostatine possédant une activité anti néovascularisation choroïdienne in vivo.

Affiliated with

Also associated with

Rating

Ocular gene therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Ocular gene therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ocular gene therapy will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1891634